Kaifeng M. Qiu
107 Yanjiang West Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A cross-sectional survey on pharmacists' protection against hazardous drugs in China based on USP <800>, NIOSH and ISOPP standards: Comparative analysis and improvement suggestions.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 26, 2026
Multivariate analysis and construction and validation of a nomogram model from data of 1610 patients with non-tumor-related anastomotic stenosis after rectal cancer surgery
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: June 20, 2024
Physiologically-based pharmacokinetic modelling to investigate the effect of CYP3A4/3A5 maturation on tacrolimus pharmacokinetics in paediatric HSCT patients.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 27, 2023
Facial palsy induced by immune checkpoint blockade: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data.
Journal: International immunopharmacology
Published: July 11, 2023
Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 10, 2023
A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab.
Journal: Expert opinion on drug safety
Published: September 30, 2022
Cost-effectiveness analysis of nivolumab plus cabozantinib versus sunitinib as first-line therapy in advanced renal cell carcinoma.
Journal: Immunotherapy
Published: June 27, 2022
Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data.
Journal: International immunopharmacology
Published: March 28, 2022
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.
Journal: Pharmacoepidemiology and drug safety
Published: January 12, 2022
Last Updated: 09/26/2026